Literature DB >> 9019365

Gene therapy for liver tumors.

Y Panis1, A R Rad, O Boyer, D Houssin, J L Salzmann, D Klatzmann.   

Abstract

Therapeutic gene transfer has progressed quite rapidly in recent years. Noticeably, it has now reached the clinical stage in both fields of inherited and acquired diseases. Numerous studies of liver-targeted gene therapy and cancer gene therapy have supported the hope that such innovative approaches may be of help in the treatment of primary or secondary liver tumors. In this article, the main strategies of experimental, hepatic cancer gene therapy in the prospect of a clinical use are reviewed.

Entities:  

Mesh:

Year:  1996        PMID: 9019365

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  2 in total

1.  Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.

Authors:  S S Yoon; N M Carroll; E A Chiocca; K K Tanabe
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

2.  Bilobar colorectal liver metastases: a new model for preclinical studies.

Authors:  Léon Maggiori; Frédéric Bretagnol; Mathilde Wagner; Caroline Hatwell; Yves Panis
Journal:  Int J Exp Pathol       Date:  2012-12       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.